{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:27:53Z","timestamp":1760898473918},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["surgjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.surg.2018.04.092","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T12:34:03Z","timestamp":1541507643000},"page":"135-141","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment strategy of end stage renal disease-related hyperparathyroidism before, during, and after the era of calcimimetics"],"prefix":"10.1016","volume":"165","author":[{"given":"Willemijn Y.","family":"van der Plas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton F.","family":"Engelsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marille","family":"Umakanthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Mather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stan B.","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh W.","family":"Delbridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Waugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Sywak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Schelto","family":"Kruijff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2018.04.092_bib0001","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.surg.2018.04.092_bib0002","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a european haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.surg.2018.04.092_bib0003","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/ndt\/gfx044","article-title":"Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: A systematic review","volume":"32","author":"van der Plas","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.surg.2018.04.092_sbref0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.surg.2018.04.092_bib0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bcp.2010.04.002","article-title":"Clinical utility of calcimimetics targeting the extracellular calcium-sensing receptor (CaSR)","volume":"80","author":"Brown","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.surg.2018.04.092_bib0006","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.suc.2009.06.011","article-title":"Secondary and tertiary hyperparathyroidism, state of the art surgical management","volume":"89","author":"Pitt","year":"2009","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.surg.2018.04.092_bib0007","unstructured":"Public summary document cinacalcet hydrochloride, tablets, 30 mg, 60 mg and 90mg, sensipar, November 2007. Canberra, Australia: Australian Government Department of Health Pharmaceutical Benefits Scheme 2008; 2017."},{"key":"10.1016\/j.surg.2018.04.092_bib0008","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1440-1797.2005.00476.x","article-title":"Parathyroidectomy in the calcimimetic era","volume":"10","author":"Elder","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.surg.2018.04.092_bib0009","author":"The Society of Hospital Pharmacists of Australia. Manufacturers alerts","year":"2015"},{"key":"10.1016\/j.surg.2018.04.092_bib0010","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.surg.2018.04.092_bib0011","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.surg.2018.04.092_bib0012","series-title":"The 39th annual ANZDATA report. Australia and New Zealand dialysis and transplant registry","author":"ANZDATA Registry","year":"2017"},{"key":"10.1016\/j.surg.2018.04.092_bib0013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1245\/s10434-016-5450-6","article-title":"Impact of the introduction of calcimimetics on timing of parathyroidectomy in secondary and tertiary hyperparathyroidism","volume":"24","author":"van der Plas","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2018.04.092_bib0014","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00423-015-1344-5","article-title":"Surgical management of secondary hyperparathyroidism in chronic kidney disease-a consensus report of the European Society of Endocrine Surgeons","volume":"400","author":"Lorenz","year":"2015","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.surg.2018.04.092_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.surg.2015.06.058","article-title":"Minimal impact of calcimimetics on the management of hyperparathyroidism in chronic dialysis","volume":"159","author":"Brunaud","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2018.04.092_bib0016","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2215\/CJN.12941213","article-title":"Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: The DOPPS study","volume":"10","author":"Tentori","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 5","key":"10.1016\/j.surg.2018.04.092_bib0017","doi-asserted-by":"crossref","first-page":"V2","DOI":"10.1093\/ndt\/gfh1049","article-title":"The clinical consequences of secondary hyperparathyroidism: Focus on clinical outcomes","volume":"19","author":"Horl","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.surg.2018.04.092_bib0018","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/01.tp.0000228923.75739.88","article-title":"High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation","volume":"82","author":"Roodnat","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.surg.2018.04.092_bib0019","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s00268-012-1560-x","article-title":"Postoperative hungry bone syndrome in patients with secondary hyperparathyroidism of renal origin","volume":"36","author":"Goldfarb","year":"2012","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2018.04.092_bib0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12882-016-0421-5","article-title":"Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism","volume":"18","author":"Ho","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.surg.2018.04.092_bib0021","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archsurg.143.8.756","article-title":"Long-term results of subtotal vs total parathyroidectomy without autotransplantation in kidney transplant recipients","volume":"143","author":"Rayes","year":"2008","journal-title":"Arch Surg"},{"key":"10.1016\/j.surg.2018.04.092_bib0022","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/nep.12801","article-title":"Total parathyroidectomy with autotransplantation versus subtotal parathyroidectomy for renal hyperparathyroidism: A systematic review and meta-analysis","volume":"22","author":"Chen","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.surg.2018.04.092_bib0023","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/j.ajkd.2013.02.366","article-title":"Bone alkaline phosphatase in CKD-mineral bone disorder","volume":"62","author":"Sardiwal","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.surg.2018.04.092_bib0024","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","article-title":"Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients","volume":"19","author":"Regidor","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.surg.2018.04.092_bib0025","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/ndt\/gfu055","article-title":"A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in japan","volume":"29","author":"Maruyama","year":"2014","journal-title":"Nephrol Dial Transplant"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606018306275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606018306275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T12:58:19Z","timestamp":1544273899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606018306275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0039606018306275"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2018.04.092","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment strategy of end stage renal disease-related hyperparathyroidism before, during, and after the era of calcimimetics","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2018.04.092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}